Tulsa Dental Products LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$19Mgeneral payments (2019-2025)
$240research payments (2019-2025)
2,223clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Waveone Gold Glider $4.5M associated (2023-2025)
- Trushape Gutta-Percha 40/06v $1.9M associated (2023-2025)
- Trunatomy Rotary File $383K associated (2023-2025)
- Calamus $324K associated (2023-2025)
- Q-Mix $300K associated (2023-2025)
- Temporary Guttapercha $157K associated (2023-2025)
- Trushape $112K associated (2023-2025)
- Endo Access Bur $48K associated (2023-2025)
- Gt Series X Obturator $25K associated (2023-2025)
- Waveone Gold Conform Fit $5,937 associated (2023-2025)
- Mseries Pluggers $1,374 associated (2023-2025)
- Ceramic $224 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Nathan Li | Lancaster, CA | General Practice (Dentist) | $5,191,406.65 |
| Michael Scianamblo | San Rafael, CA | Endodontics | $4,767,346.46 |
| Sergio Kuttler | Plantation, FL | Endodontics | $4,599,140.58 |
| Clifford Ruddle | Santa Barbara, CA | Endodontics | $933,568.88 |
| George Bruder | Stony Brook, NY | Endodontics | $793,349.03 |
| John West | Tacoma, WA | Endodontics | $567,522.62 |
| Ove Peters | San Francisco, CA | Endodontics | $309,515.80 |
| John Stropko | Prescott, AZ | Endodontics | $282,886.19 |
| James Gutmann | Dallas, TX | Endodontics | $144,575.12 |
| David Landwehr | Madison, WI | Endodontics | $131,006.60 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.